(Q33765787)

29 July 2017

1 reference

title

Opioid rotation for cancer pain: rationale and clinical aspects (English)

1 reference

29 July 2017

0 references

1 reference

Mercadante S

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

29 July 2017

1 reference

29 July 2017

volume

86

1 reference

29 July 2017

issue

9

1 reference

29 July 2017

page(s)

1856-1866

1 reference

29 July 2017

cites work

Cancer pain: management

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Clinical efficacy of methadone in patients refractory to other mu-opioid receptor agonist analgesics for management of terminal cancer pain. Case presentations and discussion of incomplete cross-tolerance among opioid agonist analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Individual variability in the response to different opioids: report of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Multiple mu opiate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

The Edmonton staging system for cancer pain: preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Opioid rotation for toxicity reduction in terminal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Alternated delta and mu receptor activation: a stratagem for limiting opioid tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Differences in efficacies between morphine and methadone demonstrated in the guinea pig ileum: a possible explanation for previous observations on incomplete opioid cross-tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

The genetics of pain and pain inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Morphine- and methadone-tolerant mice differ in cross-tolerance to other opiates. Heterogeneity in opioid mechanisms indicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Genetic influences in opioid analgesic sensitivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

The opioid ketobemidone has a NMDA blocking effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

The effect of intrinsic efficacy on opioid tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Differential right shifts in the dose-response curve for intrathecal morphine and sufentanil as a function of stimulus intensity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Differential behavioral effects induced by intrathecal microinjection of opiates: Comparison of convulsive and cataleptic effects produced by morphine, methadone, andd-Ala2-methionine-enkephalinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

21 January 2018

Methadone in cancer pain

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Morphine-3-glucuronide--a potent antagonist of morphine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Morphine intoxication in renal failure: the role of morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Morphine and morphine metabolite concentrations in cerebrospinal fluid and plasma in cancer pain patients after slow-release oral morphine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Chronic nausea and morphine-6-glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Myoclonic spasms during treatment with high doses of intravenous morphine in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Normorphine, a neurotoxic metabolite?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Central nervous system excitatory effects of meperidine in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Predictive factors and opioid responsiveness in cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

21 January 2018

Opioid responsiveness

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Opioid rotation: does it have a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

A long-term survey of morphine in cancer pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Intravenous high-dose methadone administered by patient controlled analgesia and continuous infusion for the treatment of cancer pain refractory to high-dose morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Use of the subcutaneous route for the administration of narcotics in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Epidural and subcutaneous morphine in the management of cancer pain: a double-blind cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Epidural opiates and local anesthetics for the management of cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Rectal methadone in cancer patients with pain. A preliminary clinical and pharmacokinetic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Practical use of rectal medications in palliative care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Sublingual absorption of selected opioid analgesics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

An open label study of oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Transdermal fentanyl and initial dose-finding with patient-controlled analgesia in cancer pain. A pilot study with 20 terminally ill cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Transdermal fentanyl in uncontrolled cancer pain: titration on a day-to-day basis as a procedure for safe and effective dose finding--a pilot study in 20 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

A population-based study of the coverage of cancer patients by hospice services

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Withdrawal with transdermal fentanyl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Opioid analgesia in uraemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

An update on the clinical use of methadone for cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Continuous intravenous infusion of fentanyl: case reports of use in patients with advanced cancer and intractable pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Opioid hyperexcitability: the application of alternate opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Intravenous methadone for cancer pain unrelieved by morphine and hydromorphone: clinical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

The cognitive effects of the administration of narcotic analgesics in patients with cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Organic hallucinosis in patients receiving high doses of opiates for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Subcutaneous fentanyl infusion in a patient with bowel obstruction and renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Patient-controlled analgesia with oral methadone in cancer pain: preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Equianalgesic dose/ratio between methadone and other opioid agonists in cancer pain: comparison of two clinical experiences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991101%2986%3A9%3C1856%3A%3AAID-CNCR30%3E3.0.CO%3B2-G

10.1002/(SICI)1097-0142(19991101)86:9<1856::AID-CNCR30>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference